16NZ-TLR9 shows antitumoral activity against both treated and untreated tumors in various rodent models and is characterised by a promising safety and PK/PD profile.
23High-throughput process development and screening of chromatographic conditions on a Biomek i7 Dual Hybrid automated workstation with CytivaPreDictor™plates
34The G-quadruplex ligand’s guide to selectivity - Development of a G4 Ligand-Oligonucleotide Modality that Selectively Targets Individual G4 DNA Structures
50Drug Discovery and Development platform - The national infrastructure that transforms your academic research into novel therapies at SciLifeLab, Sweden
